SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-008122
Filing Date
2020-03-31
Accepted
2020-03-31 06:41:35
Documents
3
Period of Report
2020-03-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120233-8k_biomxinc.htm 8-K 33309
2 PRESS RELEASE DATED MARCH 31, 2020 ea120233ex99-1_biomxinc.htm EX-99.1 15019
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4824
  Complete submission text file 0001213900-20-008122.txt   56314
Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 20759591
SIC: 2836 Biological Products, (No Diagnostic Substances)